Viewing Study NCT02465502


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-01-28 @ 7:23 PM
Study NCT ID: NCT02465502
Status: COMPLETED
Last Update Posted: 2018-11-07
First Post: 2015-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module